Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Transplantation

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 132 articles:
HTML format



Single Articles


    March 2024
  1. CHAPMAN B, Wong D, Sinclair M, Hey P, et al
    Reversing malnutrition and low muscle strength with targeted enteral feeding in patients awaiting liver transplant: A randomized controlled trial.
    Hepatology. 2024 Mar 8. doi: 10.1097/HEP.0000000000000840.
    PubMed     Abstract available


  2. CZIGANY Z, Putri AJ, Michalski CW, Mehrabi A, et al
    Letter to the editor: Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOTTM): A randomized, open-label, clinical trial.
    Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000811.
    PubMed    


  3. LUNSFORD KE, Panayotova G, Guarrera JV
    Response to Letter to the Editor on portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOT).
    Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000815.
    PubMed    


  4. FLORES CARVALHO M, Boteon YL, Guarrera JV, Modi PR, et al
    Obstacles to implement machine perfusion technology in routine clinical practice of transplantation: Why are we not there yet?
    Hepatology. 2024;79:713-730.
    PubMed     Abstract available


    February 2024
  5. DONGELMANS E, Erler N, Adam R, Nadalin S, et al
    Recent outcomes of liver transplantation for Budd Chiari Syndrome - a study of the European Liver Transplant Registry (ELTR) and affiliated centers.
    Hepatology. 2024 Feb 15. doi: 10.1097/HEP.0000000000000778.
    PubMed     Abstract available


  6. BARR RG, Bolondi L
    Contrast-enhanced US for HCC: Finally out from the waiting list?
    Hepatology. 2024;79:267-268.
    PubMed    


    December 2023
  7. PANAYOTOVA GG, Lunsford KE, Quillin RC 3rd, Rana A, et al
    Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOTTM): A randomized, open-label, clinical trial.
    Hepatology. 2023 Dec 13. doi: 10.1097/HEP.0000000000000715.
    PubMed     Abstract available


  8. SIDDIQUI MS, Muthiah M, Satapathy SK, Patidar K, et al
    Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantation.
    Hepatology. 2023 Dec 13. doi: 10.1097/HEP.0000000000000720.
    PubMed     Abstract available


    November 2023
  9. VAN DER MEEREN PE, Frederik de Wilde R, Sprengers D, IJzermans JNM, et al
    Benefit and harm of waiting time in liver transplantation for HCC.
    Hepatology. 2023 Nov 16. doi: 10.1097/HEP.0000000000000668.
    PubMed     Abstract available


  10. D'AMICO G, Zipprich A, Villanueva C, Sorda JA, et al
    Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements.
    Hepatology. 2023 Nov 2. doi: 10.1097/HEP.0000000000000652.
    PubMed     Abstract available


    October 2023
  11. MASPERO M, Hashimoto K, Fairchild RL, Schlegel A, et al
    Reply: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 Oct 9. doi: 10.1097/HEP.0000000000000630.
    PubMed    


  12. TANG G, Zhang L, Zhou R
    Letter to the Editor: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 Oct 9. doi: 10.1097/HEP.0000000000000624.
    PubMed    


  13. MASPERO M, Hashimoto K, Fairchild RL, Schlegel A, et al
    Reply: Acute rejection after transplantation of machine perfused livers-We have barely scratched the surface.
    Hepatology. 2023;78:E69-E71.
    PubMed    


  14. STRAVITZ RT, Fontana RJ, Karvellas C, Durkalski V, et al
    Future directions in acute liver failure.
    Hepatology. 2023;78:1266-1289.
    PubMed     Abstract available


    September 2023
  15. ZHAO X, Kotha S, Nayyar D, Ma X, et al
    Physiologic changes in the hepatopulmonary syndrome before and after liver transplant: A longitudinal and predictor analysis.
    Hepatology. 2023 Sep 21. doi: 10.1097/HEP.0000000000000605.
    PubMed     Abstract available


  16. SLOOTER CD, van den Brand FF, Lleo A, Colapietro F, et al
    Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry.
    Hepatology. 2023 Sep 4. doi: 10.1097/HEP.0000000000000589.
    PubMed     Abstract available


  17. WU WK, Alexopoulos SP, Bacchetta M
    Reply: Xenogeneic cross-circulation of ex vivo human livers or liver xenotransplantation?
    Hepatology. 2023;78:E50-E51.
    PubMed    


  18. EKSER B
    Letter to the Editor: Xenogeneic cross-circulation of ex vivo human livers or liver xenotransplantation?
    Hepatology. 2023;78:E48-E49.
    PubMed    


  19. WU WK, Ukita R, Patel YJ, Cortelli M, et al
    Xenogeneic cross-circulation for physiological support and recovery of ex vivo human livers.
    Hepatology. 2023;78:820-834.
    PubMed     Abstract available


    June 2023
  20. MASPERO M, Hashimoto K, Fairchild RL, Schlegel A, et al
    Reply: Acute rejection in liver transplantation: Time for uniform definitions.
    Hepatology. 2023 Jun 5. doi: 10.1097/HEP.0000000000000500.
    PubMed    


  21. GU Y, Yu T, Xiang Y
    Letter to the Editor: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 Jun 5. doi: 10.1097/HEP.0000000000000499.
    PubMed    


  22. EKSER B, Sucu S, Mihaylov P, Emamaullee JA, et al
    Letter to the Editor mucosal gut microbiota in primary sclerosing cholangitis before and after liver transplantation: Are there other challenges?
    Hepatology. 2023 Jun 5. doi: 10.1097/HEP.0000000000000503.
    PubMed    


    May 2023
  23. LIANG A, Jia J, Zhong K, Nie Y, et al
    Letter to the editor: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 May 26. doi: 10.1097/HEP.0000000000000482.
    PubMed    


  24. TONON M, Balcar L, Semmler G, Calvino V, et al
    Etiological cure prevents further decompensation and mortality in cirrhotic patients with ascites as the single first decompensating event.
    Hepatology. 2023 May 17. doi: 10.1097/HEP.0000000000000460.
    PubMed     Abstract available


  25. MEHTA N, Kelley RK, Yao FY
    Refining the approach to down-staging for hepatocellular carcinoma prior to liver transplantation: Patient selection, local-regional treatments, and systemic therapies.
    Hepatology. 2023 May 16. doi: 10.1097/HEP.0000000000000452.
    PubMed    


  26. FORMAN LM, Sapisochin G, Assis DN, Arrive L, et al
    Reply: Living donor liver transplantation for people with PSC.
    Hepatology. 2023;77:E97-E98.
    PubMed    


  27. AHMED A, Arshad MW, Ibrahim H
    Letter to the editor: Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis.
    Hepatology. 2023 May 1. doi: 10.1097/HEP.0000000000000429.
    PubMed    


  28. CULLARO G
    Reply: Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis.
    Hepatology. 2023 May 1. doi: 10.1097/HEP.0000000000000434.
    PubMed    


    April 2023
  29. SONG Z, Han H, Ge X, Das S, et al
    Deficiency of neutrophil high-mobility group box protein-1, in liver transplant recipients, exacerbates early allograft injury in mice.
    Hepatology. 2023 Apr 6. doi: 10.1097/HEP.0000000000000346.
    PubMed     Abstract available


    March 2023
  30. MASPERO M, Ali K, Cazzaniga B, Yilmaz S, et al
    Acute rejection after liver transplantation with machine perfusion versus static cold storage: a systematic review and meta-analysis.
    Hepatology. 2023 Mar 30. doi: 10.1097/HEP.0000000000000363.
    PubMed     Abstract available


  31. KWONG AJ, Zhang KY, Ebel N, Mannalithara A, et al
    MELD 3.0 for adolescent liver transplant candidates.
    Hepatology. 2023 Mar 22. doi: 10.1097/HEP.0000000000000352.
    PubMed     Abstract available


  32. TARLOW BD, Kim WR, Mannalithara A, Kwo PY, et al
    Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
    Hepatology. 2023;77:851-861.
    PubMed     Abstract available


    February 2023
  33. MAMMADOV RA, Visseren T, Roest HP, van der Laan LJW, et al
    Letter to Editor: the mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. is the dysbiosis index really predictive for the recurrence of psc?
    Hepatology. 2023 Feb 24. doi: 10.1097/HEP.0000000000000338.
    PubMed    


  34. HOLE MJ, Kaasen Jorgensen K, Holm K, Braadland PR, et al
    Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
    Hepatology. 2023 Feb 24. doi: 10.1097/HEP.0000000000000340.
    PubMed    


    January 2023
  35. HSU CC, Dodge JL, Weinberg E, Im G, et al
    Multi-Centered study of patient outcomes after declined for early liver transplantation in severe Alcohol-associated hepatitis.
    Hepatology. 2023 Jan 19. doi: 10.1097/HEP.0000000000000267.
    PubMed     Abstract available


  36. HEINEMANN M, Adam R, Karam V, Schramm C, et al
    Letter to the Editor: Living donor liver transplantation for people with PSC.
    Hepatology. 2023 Jan 3. doi: 10.1097/HEP.0000000000000208.
    PubMed    


    December 2022
  37. HUANG M, Jiao J, Cai H, Zhang Y, et al
    C-C motif chemokine ligand 5 confines liver regeneration by down-regulating reparative macrophage-derived hepatocyte growth factor in a forkhead box O 3a-dependent manner.
    Hepatology. 2022;76:1706-1722.
    PubMed     Abstract available


    September 2022
  38. HOLE MJ, Kaasen Jorgensen K, Holm K, Braadland PR, et al
    A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
    Hepatology. 2022 Sep 3. doi: 10.1002/hep.32773.
    PubMed     Abstract available


    June 2022
  39. TRAN NH, Munoz S, Thompson S, Hallemeier CL, et al
    Hepatocellular Carcinoma Down-Staging for Liver Transplantation in the Era of Systemic Combined Therapy with Anti-VEGF/TKI and Immunotherapy.
    Hepatology. 2022 Jun 28. doi: 10.1002/hep.32613.
    PubMed     Abstract available


  40. AHMAD A
    Letter to the Editor: Recovery and outcomes of patients denied early liver transplantation for severe alcohol-associated hepatitis.
    Hepatology. 2022 Jun 11. doi: 10.1002/hep.32607.
    PubMed     Abstract available


  41. AHMAD A
    Letter to the Editor: The Precise Relationship Between MELD and Survival Without a Liver Transplant.
    Hepatology. 2022 Jun 11. doi: 10.1002/hep.32602.
    PubMed     Abstract available


    April 2022
  42. SOUSA DA SILVA RX, Weber A, Dutkowski P, Clavien PA, et al
    Machine Perfusion in Liver Transplantation.
    Hepatology. 2022 Apr 30. doi: 10.1002/hep.32546.
    PubMed     Abstract available


  43. SINGAL AK, Kwo P, Kwong A, Liangpunsakul S, et al
    Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
    Hepatology. 2022;75:1026-1037.
    PubMed     Abstract available


  44. NEIL DAH, Minervini M, Smith ML, Hubscher SG, et al
    Banff consensus recommendations for steatosis assessment in donor livers.
    Hepatology. 2022;75:1014-1025.
    PubMed     Abstract available


    March 2022
  45. CULLARO G, Hsu CY, Lai JC
    Variability in Serum Creatinine is Associated with Waitlist and Post-Liver Transplant Mortality in Cirrhosis Patients.
    Hepatology. 2022 Mar 31. doi: 10.1002/hep.32497.
    PubMed     Abstract available


  46. FLEMMING JA, Muaddi H, Djerboua M, Neves P, et al
    Association between social determinants of health and rates of liver transplantation in individuals with cirrhosis.
    Hepatology. 2022 Mar 21. doi: 10.1002/hep.32469.
    PubMed     Abstract available


  47. BEKKI Y, Fenig Y
    Letter to the editor: The impact of donor liver fibrosis on early allograft dysfunction and ischemia-reperfusion injury.
    Hepatology. 2022;75:754.
    PubMed    


  48. VON MEIJENFELDT FA, Stravitz RT, Zhang J, Adelmeijer J, et al
    Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome.
    Hepatology. 2022;75:623-633.
    PubMed     Abstract available


  49. GOIKOETXEA-USANDIZAGA N, Serrano-Macia M, Delgado TC, Simon J, et al
    Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals.
    Hepatology. 2022;75:550-566.
    PubMed     Abstract available


    February 2022
  50. EFE C, Harputluoglu M, Karadag Soylu N, Yilmaz S, et al
    Liver transplantation following SARS-CoV-2 vaccination-induced liver failure.
    Hepatology. 2022 Feb 17. doi: 10.1002/hep.32409.
    PubMed    


  51. LEE V, Wong TC
    Reply to "prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant".
    Hepatology. 2022 Feb 2. doi: 10.1002/hep.32379.
    PubMed    


  52. GIDENER T, Yin M, Dierkhising RA, Allen AM, et al
    Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study.
    Hepatology. 2022;75:379-390.
    PubMed     Abstract available


  53. LIN T, Wang S, Munker S, Jung K, et al
    Follistatin-controlled activin-HNF4alpha-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.
    Hepatology. 2022;75:322-337.
    PubMed     Abstract available


    January 2022
  54. FRANCIS H, Kundu D, Baiocchi L
    Healthy Peribiliary Glands are Necessary for Successful Liver Transplantation.
    Hepatology. 2022 Jan 31. doi: 10.1002/hep.32382.
    PubMed    


  55. SAHAI P, Jindal A, Mukund A
    Letter to the Editor: Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant.
    Hepatology. 2022 Jan 25. doi: 10.1002/hep.32354.
    PubMed    


  56. DE VILLE DE GOYET J, Baumann U, Karam V, Verkade HJ, et al
    Organ shortage and pediatric liver transplantation: David against Goliath....
    Hepatology. 2022 Jan 14. doi: 10.1002/hep.32342.
    PubMed    


  57. ROSSIGNOL G, Muller X, Mohkam K, Dubois R, et al
    Letter to the editor: Is there a place for machine perfusion strategies in pediatric liver transplantation?
    Hepatology. 2022 Jan 13. doi: 10.1002/hep.32343.
    PubMed    


    December 2021
  58. MUSTO J, Lucey MR, Rice J
    Spontaneous recovery in patients denied early liver transplantation for severe alcoholic hepatitis-Need a closer look!
    Hepatology. 2021 Dec 10. doi: 10.1002/hep.32275.
    PubMed    


  59. JINDAL A
    Letter to the editor: Spontaneous recovery in patients denied early liver transplantation for severe alcoholic hepatitis-Need a closer look!
    Hepatology. 2021 Dec 10. doi: 10.1002/hep.32276.
    PubMed    


  60. LAI JC, Shui AM, Duarte-Rojo A, Ganger DR, et al
    Frailty, Mortality, and Healthcare Utilization after Liver Transplantation: From the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study.
    Hepatology. 2021 Dec 4. doi: 10.1002/hep.32268.
    PubMed     Abstract available


  61. FOX AN, Liapakis A, Batra R, Bittermann T, et al
    The Use of Nondirected Donor Organs in Living Donor Liver Transplantation: Perspectives and Guidance.
    Hepatology. 2021 Dec 3. doi: 10.1002/hep.32260.
    PubMed     Abstract available


  62. SAPISOCHIN G, Ivanics T, Heimbach J
    Liver Transplantation for intrahepatic cholangiocarcinoma: ready for prime time?
    Hepatology. 2021 Dec 3. doi: 10.1002/hep.32258.
    PubMed     Abstract available


    November 2021
  63. DE VILLE DE GOYET J, Baumann U, Karam V, Adam R, et al
    European Liver Transplant Registry: donor and transplant surgery aspects of 16,641 liver transplantations in children.
    Hepatology. 2021 Nov 1. doi: 10.1002/hep.32223.
    PubMed     Abstract available


  64. BARCENA-VARELA M, Lujambio A
    Dissecting Early Relapse in Liver Cancer, One Cell at a Time.
    Hepatology. 2021;74:2891-2893.
    PubMed    


    October 2021
  65. BEKKI Y, Fenig Y
    Outcomes of Severe Alcohol-Related Hepatitis with or without Early Liver Transplantation.
    Hepatology. 2021 Oct 30. doi: 10.1002/hep.32219.
    PubMed     Abstract available


  66. DE GOEIJ FHC, Schlegel A, Dutkowski P
    Reply to: Short-term data on machine perfusion for liver transplantation should be extrapolated with caution.
    Hepatology. 2021 Oct 8. doi: 10.1002/hep.32192.
    PubMed     Abstract available


    September 2021
  67. DE JONG IEM, Overi D, Carpino G, Gouw ASH, et al
    Persistent Biliary Hypoxia and Lack of Regeneration Are Key Mechanisms in the Pathogenesis of Post-transplant Non-anastomotic Strictures.
    Hepatology. 2021 Sep 20. doi: 10.1002/hep.32166.
    PubMed     Abstract available


  68. BLOOM PP, Fontana RJ
    With Alcohol as the fuel, COVID is the match: Liver Transplantation for Alcoholic liver disease is increasing in the United States.
    Hepatology. 2021 Sep 8. doi: 10.1002/hep.32141.
    PubMed     Abstract available


  69. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows.
    Hepatology. 2021 Sep 7. doi: 10.1002/hep.32097.
    PubMed    


  70. RAEVENS S, Boret M, De Pauw M, Fallon MB, et al
    Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome.
    Hepatology. 2021;74:1674-1686.
    PubMed     Abstract available


  71. STARLINGER P, Ahn JC, Mullan A, Gyoeri GP, et al
    The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Hepatology. 2021;74:1533-1545.
    PubMed     Abstract available


    August 2021
  72. VARGHESE J, Malleswaran S, Mouleeswaran K
    Letter to the Editor: Toxin-induced Graft Injury following Liver Transplantation for Yellow Phosphorus Poisoning.
    Hepatology. 2021 Aug 28. doi: 10.1002/hep.32124.
    PubMed     Abstract available


  73. HAKEEM A, Rammohan A, Vij M, Rela M, et al
    Insights into Yellow Phosphorus Induced Graft Injury following Liver Transplantation.
    Hepatology. 2021 Aug 27. doi: 10.1002/hep.32127.
    PubMed     Abstract available


  74. WADHWANI SI, Ge J, Gottlieb L, Lyles C, et al
    Racial/Ethnic Disparities in Wait List Outcomes Are Only Partly Explained by Socioeconomic Deprivation Among Children Awaiting Liver Transplantation.
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32106.
    PubMed     Abstract available


  75. MUSTO J, Stanfield D, Ley D, Lucey MR, et al
    Recovery and Outcomes of Patients Denied Early Liver Transplantation (LT) for Severe Alcohol-Related Hepatitis (AH).
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32110.
    PubMed     Abstract available


  76. FIX OK, Blumberg EA, Chang KM, Chu J, et al
    American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
    Hepatology. 2021;74:1049-1064.
    PubMed     Abstract available


  77. DUHAUT L, Eyries M, Lewin M, Ciacio O, et al
    Hepatic Arteriovenous Malformation: The Search for a PTEN Mutation!
    Hepatology. 2021;74:1121-1123.
    PubMed    


  78. FONTANA RJ, Stravitz RT, Durkalski V, Hanje J, et al
    Prognostic Value of the (13) C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury.
    Hepatology. 2021;74:961-972.
    PubMed     Abstract available


    July 2021
  79. WADHWANI SI, Gottlieb L, Bucuvalas JC, Lyles C, et al
    Addressing social adversity to improve outcomes for children after liver transplant.
    Hepatology. 2021 Jul 28. doi: 10.1002/hep.32073.
    PubMed     Abstract available


  80. CHOLANKERIL G, Goli K, Rana A, Hernaez R, et al
    Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the United States.
    Hepatology. 2021 Jul 26. doi: 10.1002/hep.32067.
    PubMed     Abstract available


  81. DE GOEIJ FHC, Schlegel A, Muiesan P, Guarrera JV, et al
    Hypothermic oxygenated machine perfusion protects from cholangiopathy in DCD liver transplantation.
    Hepatology. 2021 Jul 7. doi: 10.1002/hep.32044.
    PubMed     Abstract available


  82. EMBER KJI, Hunt F, Jamieson LE, Hallett JM, et al
    Noninvasive Detection of Ischemic Vascular Damage in a Pig Model of Liver Donation After Circulatory Death.
    Hepatology. 2021;74:428-443.
    PubMed     Abstract available


  83. GOUDSMIT BFJ, Putter H, Tushuizen ME, Vogelaar S, et al
    Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region.
    Hepatology. 2021;74:351-363.
    PubMed     Abstract available


  84. WOOD NL, Kernodle AB, Hartley AJ, Segev DL, et al
    Heterogeneous Circles for Liver Allocation.
    Hepatology. 2021;74:312-321.
    PubMed     Abstract available


    June 2021
  85. HIRAO H, Ito T, Kadono K, Kojima H, et al
    Donor Hepatic Occult Collagen Deposition Predisposes to Peri-transplant Stress and Impacts Human Liver Transplantation.
    Hepatology. 2021 Jun 25. doi: 10.1002/hep.32030.
    PubMed     Abstract available


  86. YANG Z, Zhang T, Kusumanchi P, Tang Q, et al
    Transcriptomic analysis reveals the miRNAs responsible for liver regeneration associated with mortality in alcoholic hepatitis.
    Hepatology. 2021 Jun 7. doi: 10.1002/hep.31994.
    PubMed     Abstract available


  87. WONG TC, Lee VH, Law AL, Pang HH, et al
    Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant.
    Hepatology. 2021 Jun 6. doi: 10.1002/hep.31992.
    PubMed     Abstract available


  88. ROSENBLATT R, Lee H, Liapakis A, Lunsford KE, et al
    Equitable access to liver transplant: Bridging the gaps in the social determinants of health.
    Hepatology. 2021 Jun 1. doi: 10.1002/hep.31986.
    PubMed     Abstract available


  89. KULKARNI AV, Kumar P, Sharma M, Menon B, et al
    Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better?
    Hepatology. 2021;73:2619-2620.
    PubMed    


  90. MARTINS PN, Clavien PA, Jalan R, Ghinolfi D, et al
    A Call for Randomization in Clinical Trials of Liver Machine Perfusion Preservation.
    Hepatology. 2021;73:2586-2591.
    PubMed    


  91. HOOFNAGLE JH, Bonkovsky HL, Phillips EJ, Li YJ, et al
    HLA-B*35:01 and Green Tea-Induced Liver Injury.
    Hepatology. 2021;73:2484-2493.
    PubMed     Abstract available


    May 2021
  92. MARTINEZ M, Perito ER, Valentino P, Mack CL, et al
    Recurrence of primary sclerosing cholangitis after liver transplant in children: an international observational study.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31911.
    PubMed     Abstract available


  93. MEUNIER L, Faure S, Meszaros M
    Letter to the Editor: Cancer after liver transplant: don't forget tobacco and tacrolimus.
    Hepatology. 2021 May 15. doi: 10.1002/hep.31899.
    PubMed     Abstract available


  94. PEISELER M, Tacke F
    An unexpected line of defense: hepatoprotective eosinophils in ischemia-reperfusion injury.
    Hepatology. 2021 May 11. doi: 10.1002/hep.31895.
    PubMed     Abstract available


  95. VAN DER LAAN LJW, Roos FJM, Verstegen MMA
    Bile Duct Repair in Human Liver Grafts: Effective Cholangiocyte Organoid Engraftment and Plasticity.
    Hepatology. 2021 May 2. doi: 10.1002/hep.31877.
    PubMed     Abstract available


    March 2021
  96. ROSENBLATT R, Wahid N, Halazun KJ, Kaplan A, et al
    Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
    Hepatology. 2021 Mar 29. doi: 10.1002/hep.31837.
    PubMed     Abstract available


  97. SALEM R, Johnson GE, Kim E, Riaz A, et al
    Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study.
    Hepatology. 2021 Mar 19. doi: 10.1002/hep.31819.
    PubMed     Abstract available


  98. YASUDO H, Ando T, Maehara A, Ando T, et al
    A possible association between a novel NLRP1 mutation and an autoinflammatory disease involving liver cirrhosis.
    Hepatology. 2021 Mar 19. doi: 10.1002/hep.31818.
    PubMed     Abstract available


  99. VAN WESSEL DBE, Thompson RJ, Gonzales E, Jankowska I, et al
    Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency.
    Hepatology. 2021 Mar 5. doi: 10.1002/hep.31787.
    PubMed     Abstract available


  100. VANDERWERKEN D, Wood NL, Segev D, Gentry S, et al
    The Precise Relationship Between MELD and Survival Without a Liver Transplant.
    Hepatology. 2021 Mar 2. doi: 10.1002/hep.31781.
    PubMed     Abstract available


    February 2021
  101. HERCUN J, Parikh E, Kleiner DE, Fuss I, et al
    Recurrent nodular regenerative hyperplasia post-liver transplantation in common variable immunodeficiency.
    Hepatology. 2021 Feb 27. doi: 10.1002/hep.31775.
    PubMed     Abstract available


  102. JOHN BV, Aitcheson G, Schwartz KB, Shabbir Khakoo N, et al
    Male Gender is Associated with Higher Rates of Liver-related Mortality in Primary Biliary Cholangitis and Cirrhosis.
    Hepatology. 2021 Feb 26. doi: 10.1002/hep.31776.
    PubMed     Abstract available


  103. NASSER-GHODSI N, Mara K, Watt KD
    De novo Colorectal and Pancreatic Cancer in Liver Transplant Recipients: Identifying the Higher Risk Populations.
    Hepatology. 2021 Feb 5. doi: 10.1002/hep.31731.
    PubMed     Abstract available


  104. CHEN SY, Zhang HP, Li J, Shi JH, et al
    Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor beta-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation.
    Hepatology. 2021;73:738-758.
    PubMed     Abstract available


    January 2021
  105. JIN L, Li X
    Letter to the Editor: Prognostic value of B-type natriuretic peptide in liver transplant patients.
    Hepatology. 2021 Jan 18. doi: 10.1002/hep.31721.
    PubMed     Abstract available


  106. KWON HM, Jang HY, Hwang GS
    Reply to Letter to the Editors: "Prognostic value of B-type natriuretic peptide in liver transplant patients".
    Hepatology. 2021 Jan 18. doi: 10.1002/hep.31722.
    PubMed     Abstract available


  107. SARKAR M, Brady CW, Fleckenstein J, Forde KA, et al
    Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021;73:318-365.
    PubMed    


  108. LEONIS MA, Miethke AG, Fei L, Maynor S, et al
    Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure.
    Hepatology. 2021;73:233-246.
    PubMed     Abstract available


    November 2020
  109. HAFEZI M, Lin M, Chia A, Chua A, et al
    Immunosuppressive Drug Resistant Armored TCR T cells for immune-therapy of HCC in liver transplant patients.
    Hepatology. 2020 Nov 29. doi: 10.1002/hep.31662.
    PubMed     Abstract available


  110. KWON HM, Moon YJ, Kim KS, Shin WJ, et al
    Prognostic value of B-type natriuretic peptide in liver transplant patients: Implication in post-transplant mortality.
    Hepatology. 2020 Nov 28. doi: 10.1002/hep.31661.
    PubMed     Abstract available


  111. BARMAN PM, VanWagner LB
    Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.
    Hepatology. 2020 Nov 20. doi: 10.1002/hep.31647.
    PubMed     Abstract available


  112. POLI E, Verstuyft C, Guettier C, Duclos Vallee JC, et al
    Reply to "Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and immunosuppressive drugs: causality of MMF or tacrolimus?"
    Hepatology. 2020 Nov 17. doi: 10.1002/hep.31635.
    PubMed     Abstract available


  113. LOUSTAUD-RATTI V, Anneraud A, Carrier P, Debette-Gratien M, et al
    Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and immunosuppressive drugs: causality of MMF or tacrolimus?
    Hepatology. 2020 Nov 13. doi: 10.1002/hep.31633.
    PubMed     Abstract available


    October 2020
  114. BROWN SA, Izzy M, Watt KD
    Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underutilized Potential.
    Hepatology. 2020 Oct 12. doi: 10.1002/hep.31595.
    PubMed     Abstract available


  115. WONG TC, Yan-Yue Fung J, Pang HH, Leung CK, et al
    Analysis of survival benefits of living vs. deceased donor liver transplant in high MELD and hepatorenal syndrome.
    Hepatology. 2020 Oct 2. doi: 10.1002/hep.31584.
    PubMed     Abstract available


    September 2020
  116. CHANDLER RJ, Venturoni LE, Liao J, Hubbard BT, et al
    Promoterless, nuclease-free genome editing confers a growth advantage for corrected hepatocytes in mice with methylmalonic acidemia.
    Hepatology. 2020 Sep 25. doi: 10.1002/hep.31570.
    PubMed     Abstract available


  117. TERRAULT NA, Burton J, Ghobrial M, Verna E, et al
    Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors.
    Hepatology. 2020 Sep 14. doi: 10.1002/hep.31551.
    PubMed     Abstract available


  118. DA BL, Im GY, Schiano TD
    Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Hepatology. 2020;72:1102-1108.
    PubMed     Abstract available


    August 2020
  119. KIM WH, Yang SM, Lee KH
    Letter to the Editor: Appraisal of Cardiac Ejection Fraction With Liver Disease Severity.
    Hepatology. 2020;72:783.
    PubMed    


  120. KWON HM, Hwang GS
    Reply.
    Hepatology. 2020;72:784.
    PubMed    


    June 2020
  121. KLOECKNER R, Galle PR, Bruix J
    Local and Regional Therapies for Hepatocellular Carcinoma.
    Hepatology. 2020 Jun 18. doi: 10.1002/hep.31424.
    PubMed     Abstract available


  122. RUSSO MW, Fix OK, Koteish AA, Duggan K, et al
    Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage.
    Hepatology. 2020 Jun 17. doi: 10.1002/hep.31425.
    PubMed     Abstract available


    May 2020
  123. DENEAU MR, Mack C, Perito ER, Ricciuto A, et al
    The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) index: a prognostic tool for children.
    Hepatology. 2020 May 28. doi: 10.1002/hep.31393.
    PubMed     Abstract available


  124. GUNASEKARAN G, Bekki Y, Lourdusamy V, Schwartz M, et al
    Surgical Treatments of Hepatobiliary Cancers.
    Hepatology. 2020 May 21. doi: 10.1002/hep.31325.
    PubMed     Abstract available


  125. LLOVET JM, Villanueva A, Marrero JA, Schwartz M, et al
    Trial Design and Endpoints in hepatocellular carcinoma: AASLD Consensus Conference.
    Hepatology. 2020 May 20. doi: 10.1002/hep.31327.
    PubMed     Abstract available


    April 2020
  126. CHOI J, Jo C, Lim YS
    Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection.
    Hepatology. 2020 Apr 23. doi: 10.1002/hep.31289.
    PubMed     Abstract available


  127. KHALAF RT, Sokol RJ
    New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Hepatology. 2020;71:1486-1498.
    PubMed     Abstract available


    March 2020
  128. NAGAI S, Kitajima T, Yeddula S, Salgia R, et al
    Effect of mandatory 6-month waiting period on waitlist and transplant outcomes in patients with hepatocellular carcinoma.
    Hepatology. 2020 Mar 10. doi: 10.1002/hep.31223.
    PubMed     Abstract available


  129. TANER T, Heimbach JK
    Something Wicked this Way Comes.
    Hepatology. 2020;71:1119-1121.
    PubMed    


  130. SPANN A, Yasodhara A, Kang J, Watt K, et al
    Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review.
    Hepatology. 2020;71:1093-1105.
    PubMed     Abstract available


    October 2019
  131. KAPILA N, Menon KVN, Al-Khalloufi K, Vanatta JM, et al
    HCV NAT positive solid organ allografts transplanted into HCV negative recipients: A real-world experience.
    Hepatology. 2019 Oct 28. doi: 10.1002/hep.31011.
    PubMed     Abstract available


    December 2018
  132. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Ghabril M, et al
    Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30368.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.